Groups representing hospitals that rely on the 340B program recently urged congressional advisers against recommending reduced Medicare reimbursement to 340B [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
While newly enrolled 340B hospital entrants served higher numbers of Medicaid and rural patients than non-340B hospitals, government-owned 340B hospitals [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Novo Nordisk this week announced that its contract pharmacy restrictions will soon apply to all grantee covered entities—not just [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
As 340B stakeholders continue to hold out for long-awaited congressional action that could overhaul the discount drug pricing program, some [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Just weeks after passing legislation to prohibit drugmaker 340B contract pharmacy restrictions in the state, Kansas lawmakers voted late Tuesday [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Missouri Senate yesterday overwhelmingly passed a 340B contract pharmacy access bill, two weeks after the state house passed a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Kansas Gov. Laura Kelly (D) signed a sweeping state budget bill late Wednesday that contains a provision to prohibit drugmaker [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A small business lobbying organization, created as a more conservative alternative to the U.S. Chamber of Commerce, this week launched [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B drug discount program—and congressional activity associated with it—remained a hot topic for lobbyists in the first three months [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...] …